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Abstract The endoplasmic reticulum-lysosome-Golgi net-
work plays an important role in Reelin glycosylation and its
proteolytic processing. Golgi complex fragmentation is asso-
ciated with the separation of Reelin from this network. Kainic
acid (KA) is an excitotoxic agent commonly used to induce
epilepsy in rodents. The relationship between KA-induced
neuronal damage and Golgi complex fragmentation has not
been investigated, leaving a major gap in our understanding of
the molecular mechanism underlying the development of
pathophysiology in epilepsy. We cultured primary rat cortical
neurons eitherin ambient condition (control) or treated with a
range of KA doses to reveal whether Golgi complex fragmen-
tation impaired neuronal function. The half-life maximal in-
hibitory concentration (IC50) value of KAwas detected to be
approximately 5 μM, whereby at these concentrations, KA
impaired neuronal viability, which was closely associatedwith
initial Golgi complex fragmentation and subsequent reduction
in both the expression and glycosylation patterns of Reelin.
These findings implicate that Golgi complex fragmentation
and Reelin dysfunction are key contributors to neuronal cell
death in the early stage of epilepsy pathophysiology, thereby
representing as novel disease biomarkers, as well as potent
therapeutic targets for epilepsy.
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Introduction
Epilepsy is a debilitating neurological disorder affecting ap-
proximately 2 % of the world’s population. Over three million
Americans suffer from some form of epilepsy, with mesial
temporal lobe epilepsy (TLE) being the most common, arising
from the temporal lobe structures of amygdala, hippocampus,
and parahippocampal gyrus [1]. Despite the availability of
many antiepileptic drugs (AEDs), greater than 30 % of TLE
patients will have seizures refractory to standard therapeutics,
highlighting the need for more effective therapies. [2].
The Golgi complex is localized around the centriole, a reg-
ulator of cell-cycle progression, and is a cytoplasmic organelle
that participates in maturation and modification of membrane
proteins during transport from the site of synthesis in the en-
doplasmic reticulum (ER) [3, 4]. Golgi complex fragmenta-
tion irreversibly occurs during apoptosis, when the Golgi
complex fragments to produce clusters of vesicles that dis-
perse throughout the cytoplasm [5]. The Golgi complex frag-
mentation not only is essential for cell entry into mitosis [6]
but also is a pathological feature of several neurodegenerative
diseases including Alzheimer’s disease [7], Parkinson’s dis-
ease [8], amyotrophic lateral sclerosis [9], and Creutzfeldt-
Jakob disease [10].
Reelin is an extracellular matrix glycoprotein [11] synthe-
sized and secreted by Cajal-Retzius cells in the marginal zone
of the cortex [12]. It localizes to Golgi complex [13] where it
is extensively processed within the ER-lysosome-Golgi net-
work [5]. Secreted Reelin binds the apolipoprotein 2 receptor
(ApoE2R) and the very low density lipoprotein receptor
(VLDLR) [14] as well as the extracellular domain of ephrin
B proteins (EFNBs) [15], which associate with ApoE2R and
VLDLR. These interactions in turn induce phosphorylation of
the cytoplasmic adaptor protein Disabled-1 (Dab-1) by Src
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family tyrosine kinases (SFKs), Fyn and Src, associated with
signaling of integrin pathways [16]. The physiological dys-
function of Reelin has been implicated in the pathogenesis
of several neurodegenerative diseases including epilepsy[17,
18], depression [19], schizophrenia [15], and Alzheimer’s dis-
ease [11, 20]. The ER-lysosome-Golgi network assumes a
major function in Reelin protein modification (glycosylation),
its proteolytic processing (180- and 320-kDa fragments), and
the synthesis of proteoglycans, which are composed of mole-
cules of extracellular matrix [11].
Unilateral injection of kainic acid (KA), an agonist to the
excitatory neurotransmitter glutamate, into rodent brain in-
duces epileptic activity and epileptic seizures, and granule cell
dispersion [21]. KA possesses neurotoxicity involving epilep-
togenic effect via the α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) and kainate receptors that
respond to the neurotransmitter glutamate [22]. KA-induced
caspase activation and subsequent DNA fragmentation are
key features of the apoptotic pathway leading to neuronal
death [23, 24]. However, KA-induced Golgi complex frag-
mentation remains to be examined in electrophysiological hy-
peractivity models, which mimic seizure and epilepsy.
In this study, we observed that the administration of KA in
primary rat neuronal cells promoted neuronal dysfunction by
facilitating the Golgi complex fragmentation/dispersal, which
in turn may damage a sophisticated network of biochemical
reactions involved in energy production and macromolecular
biosynthesis. The present results demonstrated that a dysfunc-




Primary rat neuronal cells (PRNCs) were obtained from
BrainBit (E18 rat cortex). According to the previous
reference[25], cells (4×104 cells/well) were suspended in
200 μl Neural Medium (NbActive 4, BrainBit NB4-500) con-
taining 2 mML-glutamine and 2 % B27 in the absence of
antibiotics and grown in poly-L-lysine-coated 96-well plates
(BD 354516) at 37 °C in humidified atmosphere containing
5 % CO2 in 40 % of the neuron and 60 % astrocyte cell
population [25]. After 3 days of culturing (approximately
60 % cell confluence), PRNCs were exposed to KA
(1.25 nM~125 μM) for 3 days at 37 °C.
Measurement of Cell Viability
Measurement of cell viability was performed by both fluores-
cent live/dead cell assay and trypan blue exclusion method
[26]. A two-color fluorescence cell viability assay was
performed by calcein acetoxymethyl ester (calcein-AM,
Invitrogen C3099) to be retained within live cells, including
an intense uniform green fluorescence and ethidium homodi-
mer (EthD-1) to bind the nuclei of damaged cells. Following
treatment, the cells were incubated with 2 μM calcein-AM
and 4 μM EthD-1 for 45 min at room temperature in the dark.
After washing once with phosphate-buffered saline (PBS)
(Sigma-Aldrich P-3813), the green fluorescence of the live
cells was measured by the Gemini EX florescence plate reader
(Molecular Device), excitation at 490 nm and emission at
520 nm. In addition, trypan blue (Gibco 15250, 0.4 %) exclu-
sion method was conducted, and mean viable cell counts were
calculated in four randomly selected areas (1 mm2, n=10) to
reveal the cell viability. Briefly, within 5 min after adding
trypan blue, we digitally captured under microscope (×200)
ten pictures (approximately 100 cells/picture) for each condi-
tion, then randomly selected five pictures, and counted the
number of cells for each individual treatment condition. Nor-
malized cell viability was calculated from the following equa-
tion: viable cells (%)=[1.00–(number of blue cells/number of
total cells)]×100. To precisely calibrate the cell viability, the
values were standardized from florescence intensity and
trypan blue data [25].
Measurement of Mitochondrial Activity
Following cell culture, reduction of 3-(4,5-dimethyl-2-
thiazoyl)-2,5-diphenyltetrazolium bromide (MTT) (Roche
11465007001) by mitochondrial dehydrogenases was used
as a measure of mitochondrial activity as previously described
[25]. Briefly, the cells were treated with 0.5 mg/ml MTT so-
lution at 37 °C for 4 h and subsequently incubated with lysis
buffer for 14 h in the incubator in a humidified atmosphere at
37 °C and 5 % CO2. The optical density of solubilized purple
forzmazan was measured at 570 nm on a Synergy HT plate
reader (Bio-Tex).
Western Blot Analysis
PRNCs were treated with CelLytic MT mammalian lysis
reagent (Sigma-Aldrich, C3228) with protease inhibitor
cocktail (Sigma-Aldrich, I3786). The lysate was centrifuged
at 3000g and 4 °C for 15 min, and the supernatant was
stored at −80 °C until used. Protein samples (10~60 μg/
lane) were run on 4~14 % Tris-Glycine SDS-PAGE gel
[27] and then transferred onto a nitrocellulose membrane
(Bio-Rad 162-0112) at 30 V, 4 °C for 14 h. The nitrocellu-
lose membranes were treated with PBS containing 0.1 %
Tween-20 and 5 % non-fat milk (Bio-Rad 170-6404) for
45 min at room temperature. Membranes were then incubat-
ed with the primary antibodies, anti-Reelin mouse antibody
(LSBio LS-C90872/49638, 1/500), anti-human natural
killer-1 (HNK1) rabbit antibody (Bioss bs-1635R, 1/500),
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anti-glyceraldehyde-3-phosphate-dehydrogenase (GAPDH)
[6C5] mouse antibody (Abcam 8245, 1/5,000), and rabbit
polyclonal anti-cis-Golgi glycoprotein of 130 kDa
(GM130, Abcam ab28049, 1/500), at 4 °C for 14 h. After
washing with PBS containing 0.1 % Tween-20 (PBST), the
nitrocellulose membrane was incubated with donkey anti-
mouse IRDye800® CW secondary antibody (LI-COR 926-
32212, 1/5000) or donkey anti-rabbit IRDye800®CW sec-
ondary antibody (LI-COR 926-32213, 1/5000) for 90 min at
room temperature in the dark. Immunoreactive detection
using near-infrared fluorescence was performed according
to protocol of Odyssey® Infrared Imaging System (LI-
COR®). Molecular weight estimation of the full-length
Reelin protein (400 kDa) and its fragments (180 and
320 kDa) using SeeBlue® Plus Pre-stained standard
(Invitrogen, LC5925) was calculated from plotting a stan-
dard curve of logarithm molecular weight versus target pro-
tein mobility.
IPAssays
After PRNC, whole cell lysate (400μg/100μl PBS containing
protease inhibitors (Sigma-Aldrich, I3786)) was interacted
with anti-Reelin mouse monoclonal antibody (LSBio LS-
C90872/49638, 1/50) at 4 °C for 16 h, and the lysate was
incubated with 50-μl Protein G agarose beads (Invitrogen
10-1241) at 4 °C for 4 h [11]. Following antibody-protein, G
complexes were washed three times with 4 °C RIPA buffer
(Sigma-Aldrich R0278), and immune complexes were recov-
ered by heating the samples at 95 °C for 5 min in Laemmli
SDS lysis buffer (Bioland Scientific LLC SAB02-01).
Immunocytochemistry Analysis
After PRNCs (8×104 cell/well) were cultured in 400-μl Neu-
ral medium containing 2 mML-glutamine and 2 % B27 in the
absence of antibiotics in poly-L-lysine 8-chamber (BD
354632) for 3 days, the cells were then exposed to 5 μM
KA for 3 days and fixed in 4 % paraformaldehyde [25]. The
cells were washed five times for 10 min in PBST. Then, they
were blocked by 5 % normal goat serum (Invitrogen 50062Z)
in PBST for 1 h at room temperature. Primary antibodies,
mouse monoclonal anti-Golgi formiminotransferase
cyclodeaminase (FTCD, Abcam ab27043, 1/400), rabbit
polyclonal anti-cis-Golgi glycoprotein of 130 kDa (GM130,
Abcam ab28049, 1/400), rabbit polyclonal anti-ERp29
(Abcam ab11420, 1/500) for detecting the ER marker protein,
rabbit polyclonal anti-LAMP (Abcam ab24170, 1/100) for
detecting the lysosome marker protein, and mouse monoclo-
nal anti-Reelin (Abcam ab78540, 1/400) were used. The cells
were incubated overnight at 4 °C with primary antibody with
5 % normal goat serum. The cells were washed five times for
10 min in PBST and then soaked in 5 % normal goat serum in
PBST containing corresponding secondary antibodies, goat
anti-mouse IgG-Alexa 488 (green, Invitrogen A11029, 1/1,
000) and goat anti-rabbit IgG-Alexa 594 (red, Invitrogen
A11037, 1/1,000) for 90 min in the dark. Finally, cells were
washed five times for 10 min in PBST and three times for
5 min in PBS, then processed for Hoechst 33258 (Sigma
B2883) for 30 min, washed in PBS, and cover-slipped with
Fluoromount. Immunofluorescent images were visualized
using confocal microscope (Olympus FV1000). Control ex-
periments were performed with the omission of the primary
antibodies yielding negative results.
Data Analysis
Data were evaluated using one-way analysis of variance
(ANOVA) followed by post hoc Bonferroni’s t tests. Statistical
significance was preset at p<0.05. Data are represented as
means ± SD from quintuplicates of each treatment condition.
The value of IC50 was calculated from the equation Y = A + [(B
− A)/(1 + (x/IC50)h) + (B − A)/(F − A) − 1], where Y is the
observed value of individual KA concentration (x), A is the y
axis value of the bottom plateau, B is maximal value, x is the
concentration of KA, h is the Hill coefficient (h≈1), F=(B +
Baseline)/2, and Baseline is the y-axis value that defines 0 %,
maximal inhibition by KA [28]. The IC50 values were estimat-
ed by plotting the logarithmic values of the different KA doses
using GraphPad Prism 6® software.
Results
Treatment of PRNCs with KA Resembles the Early Stage
of Epilepsy
PRNC viability and mitochondrial activity were significantly
decreased in a dose-dependent manner with KA administra-
tion; the estimated IC50 values for cell viability and mito-
chondrial activity are 5.89±0.185 μM and 2.79±0.515 μM,
respectively (Fig. 1). Topiramate [2,3:4,5-bis-O-(1-
methylethylidene)-b-D-fructopyranosesulfamate] (TPM,
Sigma-Aldrich T0575), a commonly used AED [21, 22],
antagonizes the AMPA/kainate receptor-mediated signaling
pathway in cultured neurons in which the drug was shown
to produce a slow depression of KA inward current activa-
tion [29]. To confirm that reduction of both cell viability and
the mitochondrial activity depends on the KA-induced acti-
vation of AMPA/kainate receptors, cell viability and the mi-
tochondrial activity were compared in the presence of both
KA and TPM with that of KA alone. After exposure to
5 μM KA, both cell viability (F2,26=73.37, p<0.0001)
(Fig. 2a) and mitochondrial activity (F2,23 =43.87,
p<0.0001) (Fig. 2b) were significantly decreased. Treatment
of PRNCs with TPM increased both cell viability and
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mitochondrial activity in PRNCs exposed to KA (p<0.05).
Altogether, these results indicate that this in vitro KA para-
digm is reminiscent of early stage epilepsy.
KA Induces the Collapse of ER-Lysosome-Golgi Network
FTCD co-localizes with GM130 on the Golgi complex mem-
brane [30]; therefore, these antibodies were used in combina-
tion to assess Golgi complex structure. Following incubation
of PRNCs in 5 μM KA (previously calculated IC50 of cell
viability) for 3 days at 37 °C, Golgi complex fragmentation/
dispersal (Fig. 3) and collapse of ER-lysosome-Golgi network
were observed (Figs. 4 and 5). This study is the first to report
that the Golgi complex fragmentation occurs in the early
stages of epilepsy in vitro. The Golgi complex not only serves
a pivotal role in trafficking of ion channels, plasma receptors,
and other transmitter molecules but also mediates transport of
exogenous molecules by retrograde and trans-synaptic signal
transduction [4]. Appropriate Golgi complex localization/
positioning is essential for the processing, sorting, and trans-
port of proteins and lipids involved in cell wound healing and
maintenance of the membrane potential [3]. We hypothesized
that Golgi complex fragmentation/dispersal influences the
processing of extracellular matrix molecule Reelin.
Golgi Complex Fragmentation/Dispersal Influences Reelin
Processing
Reelin is an extracellular matrix glycoprotein that has impor-
tant functions in brain development, adult neurogenesis, and
maintenance of synaptic plasticity [12]. Reelin is tightly reg-
ulated at ER-lysosome-Golgi network and modified at Golgi
complex [13]. Matrix metalloproteinases cleave the full-
length Reelin protein (400 kDa) into both 180- and 320-kDa
fragments [31]. The 320-kDa fragment is required for proper
protein folding and essential of signaling pathways’ activity
via the specific Reelin receptors.We found that following KA-
induced Golgi complex fragmentation, intracellular Reelin
was dispersed from the Golgi complex (Fig. 6, represented
by arrow heads and Fig. 7). Of note, there are three types of

















































Fig. 1 Dose-response effects on cell viability and relative mitochondrial
activity based on KA concentrations. After cultured PRNCs were
incubated with KA for 3 days at 37 °C, cell viability and mitochondrial
activity were measured by using calcein assay (a) and MTT assay (b),






















































Fig. 2 Topiramate (TPM) significantly reduced both cell death and
mitochondrial dysfunction induced by KA administration. Cultured
PRNCs were subjected to 5 μM KA alone, or 5 μM KA in the
presence of 50 μM TPM, or 50 μM TPM alone for 3 days at 37 °C,
then cell viability and mitochondrial activity were measured by using
calcein assay (a) and MTT assay (b). There were no significant
differences in both cell viability and mitochondrial activity between
control and 50 μM TPM only treatment. ***P<0.001
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unfortunately could not be distinguished intracellularly via
immunocytochemistry when examining these Reelin subtypes
and glycosylation. Thus, for immunocytochemistry, while the
relative distances from nuclear surface of FTCD, GM130,
Erp29, and LAMP were significantly longer in KA than con-
trols (Figs. 3–5), Reelin was detected not to significantly differ
from the controls (Fig. 6). On the other hand, protein expres-
sion (as shown in subsequent Western blot analysis) clearly
showed the changes in ratio of intracellular Reelin subtypes
and their glycosylation patterns. Accordingly, Western blot
analysis (Fig. 8a, b) revealed that the 320-kDa fragment,
representing the secreted form of Reelin[32], was significantly
decreased in KA-treated PRNCs compared to control, where-
as the full-length Reelin protein (400 kDa) in KA-treated
PRNCs was significantly increased (p<0.05), indicating that
proteolytic processing of Reelin was decreased in this acute
KA neurotoxicity paradigm that mimics the early stage of
epilepsy. Furthermore, the mobility of the top two bands in
control was slightly shorter than that of PRNCs treated with
5 μMKA for 3 days at 37 °C, demonstrating that these Reelin
fragments are more extensively processed under normal phys-
iologic conditions when compared with the KA-induced neu-
rotoxicity in vitro. Accordingly, this KA-induced epilepsy
likely contributed to the initiation of Golgi complex
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Fig. 3 Immunofluorescence showing gross changes in Golgi complex
distribution/morphology in response to KA administration with PRNCs
for 3 days at 37 °C. PRNCs were fixed and stained for the Golgi complex
using antibodies against FTCD (green) and GM130 (red) and for nuclei
using Hoechst 33258 (blue). a–c Control, FTCD, and GM130 work in
tandem with localizing closely nuclei, whereas d–f PRNCs were
incubated with 5 μM KA for 3 days at 37 °C. g Quantifications
correspond to Golgi fragmentation, distance of reconstructed anti-
FTCD, and anti-GM130 fluorescent signal from nuclear surface. In
control condition, P value of FTCD versus GM130 is 0.687, and the
value in KA condition is 0.369. KA-induced epilepsy provoked Golgi
complex fragmentation/dispersal. ***P<0.001. Scale bars=5 μm
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Fig. 4 Immunofluorescence showing gross changes interaction between
Golgi complex and ER distribution/morphology in response to KA
administration with PRNCs for 3 days at 37 °C. PRNCs were fixed and
stained for the Golgi complex and ER using antibodies against FTCD
(green) and ERp29 (red), respectively, and for nuclei using Hoechst
33258 (blue). a–c Control, Golgi closely localized with ER which
distributed around nuclei. d–f PRNCs were incubated with 5 μM KA
for 3 days at 37 °C. KA-induced epilepsy provoked Golgi complex
fragmentation/dispersal, and ER are seen dislocated around nuclei. g
Quantification of ER dislocation from nuclear surface corresponded to
distance of reconstructed anti-ERp29 fluorescent signal from nuclear
surface. **P<0.01. Scale bars=5 μm
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fragmentation and the disruption of Reelin protein processing,
subsequently resulting in dysfunctions such as decreased se-
creted Reelin, as well as impaired glycosylation.
HNK1 glycoepitope is expressed on the extracellular ma-
trix of protein Reelin and is sequentially biosynthesized by
glucuronyltransferase and/or sulfotransferase on the Golgi
complex membrane [33]. To confirm whether Golgi complex
fragmentation affects the glycosylation of Reelin, we per-
formed Western blot analysis using the anti-HNK-1 antibody
after Reelin fragments that were immunoprecipitated (de-
scribed in BMaterials and Methods^). We observed higher
levels of glycosylated Reelin (320 and 400 kDa) in the control
group when compared to our experimental group of PRNCs
treated with 5 μM KA for 3 days (Fig. 8c, d), although the
glycosylated 180-kDa Reelin fragment was similar between
groups. These data demonstrated that Golgi complex frag-
mentation impairs not only proteolytic processing of Reelin
but also its glycosylation in the Golgi apparatus (Fig. 8),
resulting in a decrease of physiologically active Reelin in the
early stages of epilepsy. Moreover, GM130 co-localizes with
FTCD on the Golgi complex membrane and is a sensor of
intracellular pH level. Here, we found that GM130 expression
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Fig. 5 Immunofluorescence showing gross changes interaction between
Golgi complex and lysosome distribution/morphology in response to KA
administration with PRNCs for 3 days at 37 °C. PRNCs were fixed and
stained for the Golgi complex and lysosome using antibodies against
FTCD (green) and LAMP (red), respectively, and for nuclei using
Hoechst 33258 (blue). a–c Control, Golgi, and lysosome are closely
localized. d–f PRNCs were incubated with 5 μM KA for 3 days at
37 °C. KA-induced epilepsy provoked Golgi complex and lysosome
dispersal. g Quantification of lysosome dispersal corresponded to
distance of reconstructed anti-LAMP fluorescent signal from nuclear
surface. *P<0.05. Scale bars=5 μm
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Fig. 6 Intracellular Reelin (white arrow) dislocated at Golgi complex
(yellow arrow) in response to KA. PRNCs were cultured with KA for
3 days at 37 °C. PRNCs were fixed and stained for Reelin and Golgi
complex using antibodies against Reelin (green) and GM 130 (red),
respectively, and for nuclei using Hoechst 33258 (blue). a–c Control,
Intracellular Reelin co-localized with Golgi complex, d–f PRNCs were
incubated with 5 μM KA for 3 days at 37 °C. g Quantification of Reelin
distribution around nuclei corresponded to distance of reconstructed anti-
Reelin fluorescent signal from nuclear surface. Scale bars=5 μm
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level under KA condition was significantly decreased (Fig. 9),
suggesting PRNCs cytosol pH became acidic.
Discussion
Epilepsy may arise from multiple genetic mutations that pro-
duce functional deficits in a variety of voltage-dependent and/
or ligand receptor-mediated ion channels. For example, dys-
function of a voltage-dependent Na+ channel in γ-
aminobutyric acid (GABA) interneurons is critically
associated with the severe myoclonic epilepsy in infancy
[34]. Despite the availability of several AEDs, which antago-
nize the activity of specific ions channels, greater than 30% of
TLE patients will have seizures that are refractory to all stan-
dard therapeutics. The precise mechanisms that contribute to
the initiation and propagation of seizure activity have not yet
been clearly defined [22]; therefore, this study sought to ex-
amine the role by which Golgi complex fragmentation initi-
ates epilepsy pathophysiology in a cell culture paradigm.
Progress in investigating epilepsy has been facilitated by
the establishment of in vitro and in vivo epilepsy models [2].
Epilepsy treatment has rationally involved AEDs [22] and
subsequently has been explored using surgical approaches


















Fig. 7 Quantification of intracellular Reelin dislocated from Golgi
complex. Comparison of distance from nuclear surface. The distribution
of intracellular Reelin consists of Golgi complex in control condition,
whereas in KA condition, the division of Reelin separated from
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Fig. 8 Golgi complex
fragmentation impairs Reelin
mobilization. a, bWestern blot
analysis using anti-Reelin mouse
antibody showed Reelin bands
(180, 320, and 400 kDa). In
healthy neurons (control), bands
of 320 and 400 kDa Reelin
mobilized shorter than that of
epilepsy model (KA). c, d IP
analysis using anti-Reelin mouse
antibody demonstrated that the
density of 320-kDa Reelin
fragment and the full-length
Reelin protein (400 kDa) in
healthy neuronal condition is
significantly higher than that of
epilepsy model, although 180-
kDa Reelin fragment is similarly

































Fig. 9 Western blotting analysis of GM130 expression in PRNCs.
Following incubation of PRNCs in 5 μM KA for 3 days at 37 °C (KA)
or in the absence of KA (control), GM130 expression level under KA
condition was significantly decreased, indicating pH acidity of PRNC
cytosol. ***P<0.001
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neurotransmission at the postsynaptic membrane, enhances
inhibitory neurotransmission by allosterically modulating
GABAA receptor-mediated Cl
− current, and reduces sponta-
neous motor seizures in rats with KA-induced epilepsy [21].
A recent study reported that KA administration into the rat
brain, resembling a chronic model of epilepsy in vivo, al-
tered the proteolytic processing of Reelin [18]. Within short
durations, following administration of KA reduced both cell
viability and the mitochondrial activity in a dose-dependent
manner (Fig. 1), and TPM significantly reduced KA-induced
neural toxicity (Fig. 2), indicating that this paradigm closely
mimicked in vitro early stage epilepsy. Our acute KA-
induced epilepsy model in neuronal cells allowed detection
of Golgi complex fragmentation/dispersal (Figs. 3–6) and
the collapse of ER-lysosome-Golgi network (Figs. 4 and
5). In consideration of this previous study [18] indicating
Reelin as closely associated with cell death in a chronic
model of epilepsy, the present data now implicate that
Reelin also may play a critical role in the early stages of
epilepsy, as a result of Golgi complex fragmentation. Addi-
tional in vivo experiments are warranted to further elucidate
the molecular mechanisms accompanying this Reelin-Golgi
complex fragmentation in epilepsy models.
Despite being linked to a significant number of neurode-
generative diseases, the role of Golgi complex fragmentation
in mediating neurodegeneration remains relatively
underexplored [23, 24]. The initiation of Golgi complex frag-
mentation in Alzheimer’s disease has been reported to involve
Cdk5 phosphorylating the pH-sensitive cis-Golgi protein
GM130, and subsequently, GM130 is digested in lysosome
[7]. Degradation of GM130 is associated with decreasing in-
tracellular pH, and its depletion interferes with ER-lysosome-
Golgi vascular trafficking [36]. We observed decreased ex-
pression of GM130 in the acute stage of KA-induced neuro-
toxicity in comparison with healthy control groups (Fig. 9).
Here, we found that epileptic activity was induced in vitro via
KA-mediated activation of glutamatergic kainate receptors
that respond to the neurotransmitter glutamate, coupled with
Golgi complex fragmentation (Figs. 3–6). Glutamate deacti-
vation occurs predominantly by glutamate transporter (EAA)
in synapse and by glutamine synthase which catalyzes gluta-
mate neutralization in adjacent glial cells. Excessive glutamate
influx overloads the neutralizing capacity of EAA and ham-
pers glutamate-glutamine recycling activity, leading to de-
creases in the intracellular pH in neurons. With these observa-
tions in mind, excessive activation of glutamate receptors on
neurons may cause extreme decrements in intracellular pH,
which appears to trigger the initiation of Golgi complex frag-
mentation and spread of seizure area in an epileptic brain. An
alternative possibility is that ROS/lipid peroxides or unexpect-
ed secondary products directly attack the Golgi complex
membranes leading to disruption of Golgi’s ultra-ribbon struc-
ture and its fragmentation.
Protein glycosylation is an important posttranslational pro-
cess that occurs at the ER-lysosome-Golgi network. Glycosyl-
ation serves to stabilize the three-dimensional structure of the
protein, allowing for selective protein interactions that permit
multiple distinct signal transduction patterns from the same
gene. Furthermore, glycosylation aids in protein folding,
affording intermediates more hydrophilic, which prevents pro-
tein aggregation, a crucial cascade event for neurodegenera-
tion. Indeed, many pathologic proteins associated with neuro-
degenerative diseases (e.g., amyloid precursor protein, β-
secretase 1, tau, α-synuclein, and superoxide dismutase) are
glycosylated [37]. Although the molecular mechanisms un-
derlying protein glycosylation disorders are quite complex, it
has been reported that interruption of the ER-lysosome-Golgi
network contributes to the progression of neurodegenerative
diseases. Processing glycosylation of Reelin is tightly regulat-
ed in ER/Golgi apparatus. Reelin expression and glycosyla-
tion patterns are altered in the frontal cortex and cerebellum of
Alzheimer’s disease patients [11]. The 180-kDa Reelin frag-
ment interacts with α3β1 integrin receptors [38] but does not
interact with ApoER2 and VLDL receptors [39]. In the pres-
ent study, protein expression and glycosylation levels of 180-
kDa Reelin fragments were comparable between control
(healthy neurons) and PRNCs treated with 5 μM KA for
3 days (albeit early stage epilepsy) (Fig. 8). Expression and
glycosylation of 320-kDa Reelin fragment were significantly
increased in control compared with the KA-treated group,
suggesting that Golgi complex fragmentation and collapse of
the ER-lysosome-Golgi network likely caused the decreased
Reelin processing which might have contributed to initiation
and progression of epilepsy. Administration of Reelin into the
hippocampus has been shown to enhance LTP as result of the
activation of SFKs, which increase N-methyl-D-aspartate
(NMDA) receptor activity [16]. These observations advance
the notion that 320-kDa Reelin fragment protein is a major
neuromodulator that (1) increases glutamatergic neurotrans-
mission mediated by the postsynaptic ApoER2 and VLDL
receptors and therefore enhances synaptic plasticity, and (2)
prevents the suppression of NMDA receptor and LTP in epi-
lepsy patient’s brains and altered expression of Reelin (frag-
ments ratio) and its signal transduction (glycosylation pat-
terns), in part, participate in the initiation of epilepsy.
The present results revealed that Golgi complex fragmen-
tation in initiation of KA neurotoxicity could decrease the
physiological function of Reelin. Golgi complex fragmenta-
tion and Reelin dysfunction may be considered as disease
biomarkers, as well as therapeutic targets for epilepsy. A
limitation of the present study is the use of rat E18 primary
cortical cultures, with all endpoint readouts performed after
3 days in vitro. Accordingly, at this stage, the neurons were
immature and had not formed any functional synaptic con-
tacts yet. In order to recognize whether the observed aber-
rations in Golgi and Reelin translate to altered functional
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synaptic connectivity of primary neurons will require the use
of mature functionally interconnected neurons. Moreover,
we recognized the need for confirming the expression and
proper localization of glutamate receptors in primary neu-
rons and complemented by in vivo data to strengthen the
clinical relevance of the findings. Given that Reelin is
expressed in GABAergic interneurons (representing a minor
neuronal population in E18 cortical neurons), additional
studies are also warranted to provide some mechanistic in-
sights how KA-induced hyperexcitability in primary neurons
alters proteolytic processing and glycosylation of Reelin in
interneurons. That epilepsy is a network disease may limit
the direct translational application of primary neurons, which
represent an artificial system with a specific number of neu-
ronal subtypes. Nonetheless, the present results provide
valuable informative data for understanding disease pathol-
ogy and developing treatments directed at targeting imma-
ture neurons expressing Golgi and Reelin dysregulation. In
this study, we report that KA irreversibly damages the en-
doplasmic reticulum-lysosome-Golgi network which then
leads to abnormal Reelin proteolytic processing. Restoring
and reinforcing the ER-lysosome-Golgi network and its in-
teraction with Reelin could be exploited as novel therapeutic
regimens for attenuating epilepsy and relevant neurodegen-
erative diseases.
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